AstraZeneca financial docs confirm Japanese firm could buy Boulder plant
BOULDER — Last month the Colorado Economic Development Commission approved a series of tax incentives to help an unnamed company take over the vacant AstraZeneca PLC plant in Boulder. At the time, BizWest speculated that the unnamed firm was likely Japanese contract drug maker AGC Biologics. AstraZeneca confirmed those suspicions this week.
Buried nearly 200 pages into the firm’s recently released annual report is a direct reference to AGC and the Boulder plant at 5550 Airport Blvd.
The two firms “signed a letter of intent Nov. 27, 2019, to sell the facility to AGC Bio, with…
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Continue reading for less than $3 per week!
Get a month of award-winning local business news, trends and insights
Access award-winning content today!
Related Posts
-
BOULDER — Sherry Daun has been hired to serve as an independent police monitor overseeing…
-
BOULDER — Applications to Boulder’s Youth Opportunities Internship Program will be accepted from city high…
-
Officials are conducting wildfire-mitigation initiatives — including tree-cutting and animal-grazing projects — after receiving $1.6…
-
Boulder’s Human Relations Fund, which supports community-initiated activities that focus on civil rights, human rights…
